Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 18;26(8):3835.
doi: 10.3390/ijms26083835.

Sex Differences in the Regulation of Interleukins in Chronic Pain: A Widely Recognized but Difficult-to-Tackle Factor

Affiliations
Review

Sex Differences in the Regulation of Interleukins in Chronic Pain: A Widely Recognized but Difficult-to-Tackle Factor

Jie Liu et al. Int J Mol Sci. .

Abstract

Chronic pain is an extremely prevalent healthcare issue that has a profound impact on individuals and society. Sex and sex hormones regulate the pain threshold differently in males and females in pain processing. However, the regulatory mechanisms of sex differences in response to painful stimuli are still unclear, which contributes to the difficulty of analgesic drug development. Interleukins mediate neuroinflammation and are involved in the development of chronic pain. Recent studies have found that sex and sex hormones are involved in the regulation of pain thresholds by interleukins. Most previous studies used male animals to study the analgesic effects of treatments due to the complexity of estrogen. This review summarizes studies that used only female animals or both sexes to examine the impact of sex on interleukin-regulated chronic pain, to provide a theoretical basis for the development of more targeted precision medicines for pain.

Keywords: chronic pain; interleukins; neuroinflammation; sex differences.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The role of IL-1β in chronic pain from studies using females only or both sexes. Abbreviations: CCI, chronic constriction injury; CRPS, complex regional pain syndromes; DRG, dorsal root ganglion; MIA, monosodium iodoacetate; MOG35–55, myelin oligodendrocyte glycoprotein peptide 35–55; MS, multiple sclerosis; NLRP, nod-like receptor protein; OA, osteoarthritis; PMCA2, plasma membrane calcium ATPase 2; RA, rheumatoid arthritis; SC, spinal cord; TRPV1, transient receptor potential vanilloid 1.
Figure 2
Figure 2
The role of IL-6 in chronic pain from studies using females only or both sexes. Abbreviations: CCI, chronic constriction injury; CCI-ION, chronic constriction injury of the infraorbital nerve; CGRP, calcitonin gene-related peptide; CNTF, ciliary neurotrophic factor; DRG, dorsal root ganglion; JAK, janus kinase; MOG35–55, myelin oligodendrocyte glycoprotein peptide 35–55; MS, multiple sclerosis; OA, osteoarthritis; RvD5, D-series resolvins 5; SC, spinal cord; STAT3, signal transducer and activator of transcription 3; TRPV1, transient receptor potential vanilloid 1.
Figure 3
Figure 3
The role of IL-23/IL-17 in chronic pain from studies using females only or both sexes. Abbreviations: CCL17, C-C motif ligand 17; COX, cyclooxygenase; DRG, dorsal root ganglion; ERα, estrogen receptor α; GM-CSF, granulocyte macrophage-colony stimulating factor; ICS, intermittent cold stress; LTTL gel, gel Long-Teng-Tong-Luo; MOG35–55, myelin oligodendrocyte glycoprotein peptide 35–55; MS, multiple sclerosis; PI3K, phosphatidylinositol 3-kinase; SC, spinal cord; TNF, tumor necrosis factor; TRPV1, transient receptor potential vanilloid 1.
Figure 4
Figure 4
The role of IL-10 in chronic pain from studies using females only or both sexes. Abbreviations: CCI, chronic constriction injury; DRG, dorsal root ganglion; GRK, G-protein-coupled receptor kinase; ICOSaa, inducible co-stimulatory molecule agonist antibody; NP, neuropathic pain; SC, spinal cord; SNI, sciatic nerve injury; SNL, spinal nerve ligation.

Similar articles

References

    1. Kennedy J., Roll J.M., Schraudner T., Murphy S., McPherson S. Prevalence of persistent pain in the U.S. adult population: New data from the 2010 national health interview survey. J. Pain. 2014;15:979–984. doi: 10.1016/j.jpain.2014.05.009. - DOI - PubMed
    1. Goldberg D.S., McGee S.J. Pain as a global public health priority. BMC Public Health. 2011;11:770. doi: 10.1186/1471-2458-11-770. - DOI - PMC - PubMed
    1. van Hecke O., Austin S.K., Khan R.A., Smith B.H., Torrance N. Neuropathic pain in the general population: A systematic review of epidemiological studies. Pain. 2014;155:654–662. doi: 10.1016/j.pain.2013.11.013. - DOI - PubMed
    1. Hamood R., Hamood H., Merhasin I., Keinan-Boker L. Chronic pain and other symptoms among breast cancer survivors: Prevalence, predictors, and effects on quality of life. Breast Cancer Res. Treat. 2018;167:157–169. doi: 10.1007/s10549-017-4485-0. - DOI - PubMed
    1. Guan X.H., Fu Q.C., Shi D., Bu H.L., Song Z.P., Xiong B.R., Shu B., Xiang H.B., Xu B., Manyande A., et al. Activation of spinal chemokine receptor CXCR3 mediates bone cancer pain through an Akt-ERK crosstalk pathway in rats. Exp. Neurol. 2015;263:39–49. doi: 10.1016/j.expneurol.2014.09.019. - DOI - PubMed

LinkOut - more resources